Close Menu

Books in a Library

cryoglobulinaemia

Treatment of One Case with Cryoglobulinaemia Secondary to Connective Tissue Disease by Small Doses of Rituximab

Issue: 
DOI: 
10.7727/wimj.2014.384
Pages: 
398-400

Abstract

Objective: This study aims to observe the clinical efficacy of low-dose rituximab patients with cryoglobulinaemia secondary to connective tissue diseases.

Methods: Rituximab (100 mg) was infused in patients once a week for four weeks, combined with prednisone (20 mg) once a day and reduced regularly. The treatment effect was observed regularly.

Accepted: 
06 Jan, 2015
PDF Attachment: 
Journal Sections: 
e-Published: 04 Apr, 2016
Subscribe to RSS - cryoglobulinaemia
Top of Page